Navigation Links
Children's Hospital Boston, CompuCyte Corporation Establish International Quantitative Imaging Cytometry Center
Date:6/18/2009

BOSTON, June 18 /PRNewswire/ -- Children's Hospital Boston and CompuCyte Corporation today announced the establishment of an International Quantitative Imaging Cytometry Center of Excellence in Boston, to be jointly run by the two organizations. Under their agreement, Children's Hospital Boston and CompuCyte will create an educational resource focusing on training programs and symposia for scientists using laser scanning cytometry in cell- and tissue-based research. The Center represents an expansion of the existing Centers of Excellence programs currently operating at Cold Spring Harbor Laboratory in New York and the National University of Singapore.

Under the agreement, the Center will hold an annual symposium devoted to advances in Quantitative Imaging Cytometry. The first symposium is planned for August 2010 at Children's Hospital Boston.

"The establishment of the QIC Center at Children's Hospital Boston is the outgrowth of productive collaborations between research teams in the Longwood Medical Area and CompuCyte Corporation," said Dr. Leslie Silberstein, Director of the Joint Program in Transfusion Medicine and Center for Human Cell Therapy at Children's Hospital Boston. "We anticipate that the QIC Center, and the annual symposium in particular, will foster cross-disciplinary collaborations employing quantitative image cytometry in a multiplicity of cancer and stem cell research programs."

"The creation of a worldwide network of QIC Centers has been prompted by the rapidly expanding quantitative imaging cytometry network based on CompuCyte's laser scanning cytometry technology, and the growing number of applications to which it is being applied, especially in the areas of cancer and stem cell research," said Dr. Elena Holden, CompuCyte's President and CEO. "The Boston area's international reputation as an important hub of life science research and education makes it a natural site for the Center's operation, and we are pleased to partner with Children's Hospital Boston in this endeavor."

An advisory committee consisting of recognized experts in the field of cellular research will guide the Center:

  • Leslie Silberstein, M.D., Director of the Joint Program in Transfusion Medicine, Children's Hospital Boston and Professor of Pathology, Harvard Medical School

  • Robert Hongbo Luo, Ph.D., Assistant Professor of Pathology, Joint Program in Transfusion Medicine, Children's Hospital Boston, Harvard Medical School

  • Jerome Ritz, M.D., Medical Director, Connell and O'Reilly Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School

  • Lynda Chin, M.D., Dana Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School

  • James Jacobberger, Ph.D., Professor of Oncology, Case Western Reserve University and Director, Cell Analysis Core, Case Comprehensive Cancer Center, Cleveland OH

  • Elena Holden, M.D., President and CEO, CompuCyte Corporation

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, 11 members of the Institute of Medicine and 12 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. The hospital has a long and collaborative history with most of the local academic and health care institutions and private industry partners in promoting basic and translational research. Its partnerships reach beyond Boston, throughout New England to many other U.S. academic and health care institutions and pharmaceutical companies. It currently has research agreements with more than 235 industry partners. For more information about the hospital and its research, visit www.childrenshospital.org.

CompuCyte Corporation, a private company headquartered in Westwood, Massachusetts, is a leader in the development of cellular analysis instrumentation for life science research, drug safety, toxicology studies and clinical trials. The company's iCyte(R), iCys(R), and iColor(R) cytometers enable quantitative cytometric image analysis of cellular and tissue specimens. More information about the technology may be found at www.compucyte.com.


'/>"/>
SOURCE CompuCyte Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 200 Families of Children With Serious Eye Problems Benefit From Unique Gift Card Program at The Vision Center at Childrens Hospital Los Angeles
2. Childrens Bedding Naturally Enhances Emotional Well-being
3. Cydcor Builds Bears and Bonds in Special Charity Event Benefitting Childrens Hospital Los Angeles
4. National Childrens Study Begins Recruiting
5. Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles
6. Siegel+Gale Designs New HOPE Portal for Childrens Hospital Los Angeles
7. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
8. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
9. St. Charles Surgical Hospital Announces Dedicated Lymphedema Treatment Program
10. U.S. News & World Report Ranks Children's National Medical Center among Best Children's Hospitals
11. Childrens Hospital of Philadelphia Earns Highest Combined US News Score in 10 Specialties Ranked by U.S. News & World Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... Sue Desmond-Hellmann, ... Class of 2016 to stretch the limits of human possibility in her keynote address ... p.m. in the Georgia Dome. , Drawing on her rich experience as a scientist, ...
(Date:5/3/2016)... ... , ... Calvary Hospital recently hosted a reception to mark a new music ... at Mary, Manning Walsh Home (MMW) in Manhattan. , During the school year, ... hour, once a week. The music brings a lot of joy to the patients, ...
(Date:5/3/2016)... NJ (PRWEB) , ... May 03, 2016 , ... ... BCBSNJ) today announced that it has been honored as one of the nation’s ... the 2016 InformationWeek Elite 100. Horizon received the recognition for technology achievements that ...
(Date:5/3/2016)... Springs, FL (PRWEB) , ... May 03, 2016 ... ... nation’s leading innovative specialty pharmacies, will be represented at the 2016 Asembia ... Las Vegas. The Asembia Summit is the largest U.S. health care conference for ...
(Date:5/3/2016)... ... May 03, 2016 , ... Empyrean ... launching a new client service center in La Vergne, Tennessee, near Nashville. The ... the full range of Empyrean client services. , “Our Nashville-area center allows us ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016 BioNovus ... Center,s Institute for Advancing Medical Innovation (IAMI) today ... new drugs, diagnostics and medical devices. ... Innovations with rights to license, develop and commercialize ... "This partnership represents a significant ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)...  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease ... ... ... ... ...
Breaking Medicine Technology: